Slagle Financial, LLC

Position in AMGN — Amgen Inc

CIK 1984918 Edwardsville, IL

Position in AMGN

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$3,294,567

+$256,695 QoQ

Shares Held

9,098

+5.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.27%

of 13F equity value

Holder Rank

#1,024

of 3,149 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Slagle Financial, LLC holds $9,819,740 across 7 Drug Manufacturers - General names. AMGN ranks #2 (33.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	16,066	$4,080,282
2	AMGN	Amgen Inc This page	9,098	$3,294,567
3	ABBV	AbbVie Inc.	5,092	$1,281,350
4	LLY	ELI LILLY & Co	413	$495,364
5	MRK	Merck & Co., Inc.	1,761	$226,288
6	PFE	Pfizer Inc	9,185	$221,174
7	GILD	Gilead Sciences, Inc.	1,747	$220,715

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,294,567	9,098	+5.4%	Shares	Sole	2026-07-29
2026-03-31	$3,037,872	8,634	+1.8%	Shares	Sole	2026-05-01
2025-12-31	$2,776,570	8,483	+1.2%	Shares	Sole	2026-01-26
2025-09-30	$2,366,247	8,385	+3.1%	Shares	Sole	2025-11-06
2025-06-30	$2,269,698	8,129	+3.5%	Shares	Sole	2025-08-11
2025-03-31	$2,446,290	7,852	+4.9%	Shares	Sole	2025-04-30
2024-12-31	$1,951,151	7,486	+11.0%	Shares	Sole	2025-02-12
2024-09-30	$2,172,984	6,744	+7.9%	Shares	Sole	2024-10-31
2024-06-30	$1,952,812	6,250	+13.2%	Shares	Sole	2024-07-24
2024-03-31	$1,569,162	5,519	+131.3%	Shares	Sole	2024-05-16
2023-12-31	$687,215	2,386	+101.5%	Shares	Sole	2024-03-05
2023-09-30	$318,211	1,184	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.